The worldwide non-invasive aesthetic treatment market was valued at US$61.2 billion in 2022, with a predicted compounding annual growth rate of 15.4% until 2030 (Grand Review Research).
It’s no surprise then that there is an incredibly high demand for procedures that refresh, rejuvenate, recontour, reshape and ultimately reveal a more youthful appearance; in fact, skin rejuvenation treatments rank #2 among the fastest growing categories.
With the evolution of skin rejuvenation treatments over the past decade, and the recent updates to regulations for the non-surgical market, as published by AHPRA, the time for taking consultation seriously couldn’t be more relevant.
This episode explores the increasingly important BACKBONE of treatment – INFORMED CONSENT. A consultation process should always result in this outcome. Beyond the ‘boring’ paperwork, our clients and patients require thorough education of their proposed treatment program (the good, the possibly bad and the even unlikely complications) in order to provide their informed consent to the treatment, prior to it being performed.
We’ll explore why this element of a treatment is the key to safe practice and clinic-business longevity as the industry continues to evolve in a fast paced, instant gratification culture, where scope may blur due to undefined parameters being in place.
This podcast has been made possible with the support of pHformula Australia, the Australian and New Zealand distributor of pHformula, dermatological skin resurfacing. www.phformula.com.au